MedPath

THALOMID

THALOMID

Approved
DIN Number

02355191

Drug Class

Human

Market Date

Nov 1, 2010

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02355191
AIG Number0152770001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX02 THALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification92:20.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

THALIDOMIDEActive
Strength: 50 MG
Monograph: THALIDOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.